New spectacle lenses aim to make myopia control more comfortable for kids

NCT ID NCT07683481

Not yet recruiting Disease control Sponsor: Essilor International Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study compares two types of spectacle lenses designed to slow the progression of myopia (nearsightedness) in children aged 6 to 10. The goal is to see if the new test lenses are as comfortable and easy to adapt to as the control lenses during the first two weeks of wear. Children wear the assigned lenses for two weeks and answer questionnaires about their comfort and any symptoms. The study focuses on early adaptation and satisfaction, not on how well the lenses control myopia over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HADAL Spectacle Lenses
What this could lead to: If successful, this could offer children a more comfortable option for myopia control lenses, potentially improving daily wear and compliance.
What could go wrong: This is a small, short-term study (20 children, 2 weeks) focused on comfort, not on slowing myopia progression. Results may not reflect long-term use or effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia Personal Satisfaction refractive error

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOPIA

More trials for these conditions

Other studies related to the condition(s) this trial covers.